CCO Conference Highlights from the 2020 ESMO Virtual Congress

September 19-21, 2020; Virtual Conference
Download this summary slideset that includes key data from studies in breast, lung, genitourinary, and gastrointestinal cancers presented at the 2020 ESMO Virtual Congress.
Yelena Y. Janjigian, MD
Joyce O'Shaughnessy, MD
Elizabeth R. Plimack, MD, MS
person default
Vamsidhar Velcheti, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.86 MB
Released: October 23, 2020


Supported by an educational grant from
Bristol-Myers Squibb

Related Content

In this slideset from Clinical Care Options, a panel of international experts review the role of PARP inhibitors for patients with metastatic breast cancer.

person default Pierfranco Conte, MD Véronique Diéras, MD Mark E. Robson, MD Released: November 24, 2020

Downloadable summary slideset on established and emerging biomarkers critical to optimal treatment of patients with advanced NSCLC, from CCO

Nathan Pennell, MD, PhD Laura J. Tafe, MD Released: November 24, 2020

Commentary from Dr. Sandip Patel on emerging therapies targeting HER2, HER3, and TROP2 in NSCLC, from Clinical Care Options (CCO)

Sandip P. Patel, MD Released: November 23, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.